OUR PURPOSE
Committed to the therapeutic potential of medical cannabis

We enable healthcare professionals to effectively use medical cannabis as an evidence-based treatment option. So that patients can not only have safe access to medical cannabis, but also rely on expert medical care in this field.
01
Education
02
Wholesale
03
Pharmacy
OUR EXPERTISE
We’ve got it covered –
whatever you need
Providing in-depth training sessions to physicians, therapists, pharmacists and other healthcare professionals.
Offering a reliable and stable product supply that meets pharmaceutical GDP/GMP quality standards to the healthcare sector.
Own pharmacy Stauffacher Apotheke in Zurich.


Educational journal pharmActuel - Accredited with 25 FPH credits
Publication date: 11/03/2025
Cannabis sativa L. has been officially recognised as a medically legal medicinal plant in Switzerland since 1st of August 2022. Medicines containing THC and CBD can be prescribed by doctors with therapeutic freedom for the corresponding indications and are increasingly becoming a successful treatment option. Phytotherapy has thus regained a new, potent medicinal plant in its repertoire, which is also used in hard indications such as spasticity in multiple sclerosis, neuropathic pain or forms of paediatric epilepsy.
The monographs for cannabis flowers of PH HELV 12 CH311 and PH EUR 3028 provided the basis for the development of cannabis extracts and other formulations in the magistral formula area.
Cannabis pharmaceuticals represent a new challenge for pharmacies due to the highly dynamic nature of various stakeholders and demanding patients. At the same time, there are still regulatory hurdles in the implementation and qualitative aspects in the area of raw materials challenge pharmacists in the analytical in the analytical field. This training journal provides you with the knowledge you need to be prepared when you receive a prescription for medicinal cannabis or if you want to specialise your pharmacy accordingly.
OUR MANAGEMENT
Differences make the difference
With our top management we have two people leading, who have been operating and researching in the area of medical cannabis for several years: Andrew Petronanos and Dr. Simon Nicolussi.
Different qualities that complement each other, Andrew and Simon are a team of seasoned professionals and pioneers in the field of medical cannabis.

Andrew D. Petronanos
CEO & Founder

Dr. Simon Nicolussi
Chief Scientific Officer,
Medical Affairs